Erythropoietin (EOP) is a type of cytokine produced by regulative erythrocytes, it’s mainly used as replacement therapy for renal-failure or cancerous patients who’re taking kidney dialysis treatment, in order to cure anemia. To keep marrow continuously producing erythrocyte, patients have to decide the frequency of medication according to the half life of the drug’s intravital metabolism; in this aspect, developing long-acting EPO to reduce its medication frequency not only could help relieving patient’s pain, but also have profound economic meaning. ...   >>Read More